Literature DB >> 29087547

Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults.

Joanne Guay1, Rebecca L Johnson, Sandra Kopp.   

Abstract

BACKGROUND: It is estimated that over 300,000 total hip replacements are performed each year in the USA. For European countries, the number of hip replacement procedures per 100,000 people performed in 2007 varied from less than 50 to over 250. To facilitate postoperative rehabilitation, pain must be adequately treated. Peripheral nerve blocks and neuraxial blocks have been proposed to replace or supplement systemic analgesia.
OBJECTIVES: We aimed to compare the relative effects (benefits and harms) of the different nerve blocks that may be used to relieve pain after elective hip replacement in adults. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 12, 2016), MEDLINE (Ovid SP) (1946 to December Week 49, 2016), Embase (Ovid SP) (1980 to December week 49, 2016), CINAHL (EBSCO host) (1982 to 6 December 2016), ISI Web of Science (1973 to 6 December 2016), Scopus (from inception to December 2016), trials registers, and relevant web sites. SELECTION CRITERIA: We included all randomized controlled trials (RCTs) performed in adults undergoing elective primary hip replacement and comparing peripheral nerve blocks to any other pain treatment modality. We applied no language or publication status restrictions. DATA COLLECTION AND ANALYSIS: Data were extracted independently by two review authors. We contacted study authors. MAIN
RESULTS: We included 51 RCTs with 2793 participants; of these 45 RCTs (2491 participants: peripheral nerve block = 1288; comparators = 1203) were included in meta-analyses. There are 11 ongoing studies and three awaiting classification.Compared to systemic analgesia alone, peripheral nerve blocks reduced: pain at rest on arrival in the postoperative care unit (SMD -1.12, 95% CI -1.67 to -0.56; 9 trials, 429 participants; equivalent to 3.2 on 0 to 10 scale; moderate-quality evidence); risk of acute confusional status: risk ratio (RR) 0.10 95% CI 0.02 to 0.54; 1 trial, 225 participants; number needed to treat for additional benefit (NNTB) 12, 95% CI 11 to 22; very low-quality evidence); pruritus (RR 0.16, 95% CI 0.04 to 0.70; 2 trials, 259 participants for continuous peripheral nerve blocks; NNTB 4 (95% CI 4 to 8); very low-quality evidence); hospital length of stay (SMD -0.75, 95% CI -1.02 to -0.48; very low-quality evidence; 2 trials, 249 participants; equivalent to 0.75 day). Participant satisfaction increased (SMD 0.67, 95% CI 0.45 to 0.89; low-quality evidence; 5 trials, 363 participants; equivalent to 2.4 on 0 to 10 scale). We did not find a difference for the number of participants walking on postoperative day one (very low-quality evidence). Two nerve block-related complications were reported: one local haematoma and one delayed persistent paresis.Compared to neuraxial blocks, peripheral nerve blocks reduced the risk of pruritus (RR 0.33, 95% CI 0.19 to 0.58; 6 trials, 299 participants; moderate-quality evidence; NNTB 6 (95% CI 5 to 9). We did not find a difference for pain at rest on arrival in the postoperative care unit (moderate-quality evidence); number of nerve block-related complications (low-quality evidence); acute confusional status (very low-quality evidence); hospital length of stay (low quality-evidence); time to first walk (low-quality evidence); or participant satisfaction (high-quality evidence).We found that peripheral nerve blocks provide better pain control compared to systemic analgesia with no major differences between peripheral nerve blocks and neuraxial blocks. We also found that peripheral nerve blocks may be associated with reduced risk of postoperative acute confusional state and a modest reduction in hospital length of stay that could be meaningful in terms of cost reduction considering the increasing numbers of procedures performed annually. AUTHORS'
CONCLUSIONS: Compared to systemic analgesia alone, there is moderate-quality evidence that peripheral nerve blocks reduce postoperative pain, low-quality evidence that patient satisfaction is increased and very low-quality evidence for reductions in acute confusional status, pruritus and hospital length of stay .We found moderate-quality evidence that peripheral nerve blocks reduce pruritus compared with neuraxial blocks.The 11 ongoing studies, once completed, and the three studies awaiting classification may alter the conclusions of the review once assessed.

Entities:  

Mesh:

Year:  2017        PMID: 29087547      PMCID: PMC6485776          DOI: 10.1002/14651858.CD011608.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  112 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  Fascia iliaca block for analgesia after hip arthroplasty: a randomized double-blind, placebo-controlled trial: unsound statistical analysis?

Authors:  Rebecca Rowley; Russel Emamdee
Journal:  Reg Anesth Pain Med       Date:  2013 Sep-Oct       Impact factor: 6.288

3.  Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous femoral nerve sheath block on rehabilitation after unilateral total-hip arthroplasty.

Authors:  François J Singelyn; Tanguy Ferrant; Marie F Malisse; Daniel Joris
Journal:  Reg Anesth Pain Med       Date:  2005 Sep-Oct       Impact factor: 6.288

4.  Continuous lumbar plexus block--analgesia for femoral neck fractures.

Authors:  E Brands; V I Callanan
Journal:  Anaesth Intensive Care       Date:  1978-08       Impact factor: 1.669

5.  Blood loss reduced during hip arthroplasty by lumbar plexus block.

Authors:  R Twyman; T Kirwan; M Fennelly
Journal:  J Bone Joint Surg Br       Date:  1990-09

6.  [Iliofascial versus epidural block during hip endoprosthesis].

Authors:  D B Borisov; A A Kapinos; A A Tiuriapin; A V Shevelev; N A Istomina
Journal:  Anesteziol Reanimatol       Date:  2012 May-Jun

Review 7.  The use of ultrasound guidance for perioperative neuraxial and peripheral nerve blocks in children.

Authors:  Joanne Guay; Santhanam Suresh; Sandra Kopp
Journal:  Cochrane Database Syst Rev       Date:  2016-02-19

8.  Ultrasound-guided lumbar plexus block using a transverse scan through the lumbar intertransverse space: a prospective case series.

Authors:  Manoj Kumar Karmakar; Jia Wei Li; Wing Hong Kwok; Admir Hadzic
Journal:  Reg Anesth Pain Med       Date:  2015 Jan-Feb       Impact factor: 6.288

9.  Inpatient falls after total knee arthroplasty: the role of anesthesia type and peripheral nerve blocks.

Authors:  Stavros G Memtsoudis; Thomas Danninger; Rehana Rasul; Jashvant Poeran; Philipp Gerner; Ottokar Stundner; Edward R Mariano; Madhu Mazumdar
Journal:  Anesthesiology       Date:  2014-03       Impact factor: 7.892

Review 10.  Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery.

Authors:  Joanne Guay; Mina Nishimori; Sandra Kopp
Journal:  Cochrane Database Syst Rev       Date:  2016-07-16
View more
  16 in total

1.  Adductor canal blocks for postoperative pain treatment in adults undergoing knee surgery.

Authors:  Alexander Schnabel; Sylvia U Reichl; Stephanie Weibel; Peter K Zahn; Peter Kranke; Esther Pogatzki-Zahn; Christine H Meyer-Frießem
Journal:  Cochrane Database Syst Rev       Date:  2019-10-26

2.  Influence of obstructive sleep apnea on postoperative cognitive dysfunction in elderly patients undergoing joint replacement.

Authors:  Wei-Qian Wu; Wen-Biao Zheng; Hai-Bao Wang; Jian-Hua Han; Yang Huang; Chong-Yang Wang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Reducing transfusion in hip arthroplasty: tranexemic acid diminishes influence of anesthesia administered.

Authors:  Dylan B Combs; Amelia Hummel; Scott T Nishioka; Samantha N Andrews; Cass K Nakasone
Journal:  Arch Orthop Trauma Surg       Date:  2022-08-22       Impact factor: 2.928

4.  Hip fracture management in the emergency department and its impact on hospital outcomes: a retrospective cross-sectional analysis.

Authors:  Chiann Ni Thiam; Hui Min Khor; Gordon Hwa Mang Pang; Wan Chieh Lim; Tharshne Shanmugam; C Sankara Kumar Chandrasekaran; Simmrat Singh; Mohd Idzwan Bin Zakaria; Terence Ong
Journal:  Eur Geriatr Med       Date:  2022-05-14       Impact factor: 3.269

5.  Transmuscular Quadratus Lumborum and Lateral Femoral Cutaneous Nerve Block in Total Hip Arthroplasty.

Authors:  Jinlei Li; Feng Dai; Kimberly E Ona Ayala; Bin Zhou; Robert B Schonberger; Avijit Sharma
Journal:  Clin J Pain       Date:  2021-05-01       Impact factor: 3.423

6.  Total hip arthroplasty and peripheral nerve blocks: Limited but salient role?

Authors:  Asha Tyagi; Rashmi Salhotra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Jul-Sep

7.  Lateral femoral cutaneous nerve block with different volumes of Ropivacaine: a randomized trial in healthy volunteers.

Authors:  Frederik Vilhelmsen; Mariam Nersesjan; Jakob Hessel Andersen; Jakob Klim Danker; Leif Broeng; Daniel Hägi-Pedersen; Ole Mathiesen; Kasper Højgaard Thybo
Journal:  BMC Anesthesiol       Date:  2019-08-28       Impact factor: 2.217

Review 8.  The effect of fascia iliaca block on postoperative pain and analgesic consumption for patients undergoing primary total hip arthroplasty: a meta-analysis of randomized controlled trials.

Authors:  Wenli Dai; Xi Leng; Xiaoqing Hu; Jin Cheng; Yingfang Ao
Journal:  J Orthop Surg Res       Date:  2021-07-09       Impact factor: 2.359

9.  Anaesthetic management in a patient with progressive supranuclear palsy.

Authors:  Antoine Abi Lutfallah; Christine Dagher; Nicole Naccache; Patricia Yazbeck
Journal:  Indian J Anaesth       Date:  2018-08

Review 10.  The efficacy of fascia iliaca compartment block for pain control after total hip arthroplasty: a meta-analysis.

Authors:  Xiao-Yan Zhang; Jian-Bao Ma
Journal:  J Orthop Surg Res       Date:  2019-01-25       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.